InvestorsHub Logo
Followers 11
Posts 1455
Boards Moderated 0
Alias Born 02/01/2013

Re: None

Saturday, 02/11/2017 4:18:06 AM

Saturday, February 11, 2017 4:18:06 AM

Post# of 10487
I was worried about pharma being at risk from ONVO since they were still pink sheets. But the reality is, even if "big pharma" could squash ONVO, the government already has this tech and the patents rights. ONVO's IP for the most part sprang from fed funded R&R at university. So, even if "pharma" could short sell or otherwise attempt to squash this tech, then they would just then be at the hands of Uncle Sam dolling out therapeutic parts to servicemen and their families.
But much less machiavellian, and more likely scenario is a buy out. Guess what, Boston Scientific bought Guidant for 27 Billion. Six Years Ago


Frankly I do like being able to average down on dips like this. Been kicking myself for missing the low 3s last time.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONVO News